Antagonistic effects of [Nphe1]nociceptin(1-13)NH2 on nociceptin receptor mediated inhibition of cAMP formation in Chinese ovary hamster cells stably expressing the recombinant human nociceptin receptor

Neuroscience Letters

Volumn 278, Issue 1-2, 2000, Pages 109-112

  Hashimoto, Y ^a   Calo', G ^b   Guerrini, R ^b   Smith, G ^a   Lambert, D G ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Nphe1 nociceptin(1 13)NH2; Antagonist; cAMP; Nociceptin orphanin FQ

Indexed keywords

ADENYLATE CYCLASE; BUPRENORPHINE; CYCLIC AMP; FORSKOLIN; HEXAPEPTIDE; NOCICEPTIN; NOCICEPTIN RECEPTOR; PSEUDOPEPTIDE; RECOMBINANT RECEPTOR; CAM 6369; HYBRID PROTEIN; NOCICEPTIN (1 13) NH2, NPHE(1); NOCICEPTIN (1 13) NH2, PHE(1) PSI(CH2 NH) GLY(2); NOCICEPTIN (1 17) NH2, PHE(1) PSI(CH2NH) GLY(2); NOCICEPTIN (1-13)-NH2, PHE(1)-PSI(CH2-NH)-GLY(2)-; NOCICEPTIN (1-17)-NH2, PHE(1)-PSI(CH2NH)-GLY(2)-; NOCICEPTIN-(1-13)-NH2, NPHE(1)-; OLIGOPEPTIDE; OPIATE PEPTIDE; OPIATE RECEPTOR; PEPTIDE FRAGMENT;

AGONIST; ANIMAL CELL; ARTICLE; CHO CELL; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BINDING COMPETITION; BIOSYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; CRICETULUS; DRUG POTENTIATION; GENETIC TRANSFECTION; GENETICS; HAMSTER; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; BINDING, COMPETITIVE; BUPRENORPHINE; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC AMP; HUMANS; MOLECULAR STRUCTURE; OLIGOPEPTIDES; OPIOID PEPTIDES; PEPTIDE FRAGMENTS; RECEPTORS, OPIOID; RECOMBINANT FUSION PROTEINS; TRANSFECTION;

EID: 0033621642     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00915-5     Document Type: Article

References (27)

1. Bauer M., Nakazi M., Kathmann M., Gothert J., Schlicker E. The stereoselective kappa opioid receptor antagonist Mr 2266 does not exhibit stereoselectivity as an antagonist at the orphan opioid (ORL1)receptor. Naunyn Schmiedeberg's Arch. Pharmacol. 359:1999;17-20.
2. 2 of G protein activation in rat brain preparations and of chronotropic effect on rat cardiomyocytes evoked by nociceptin/orphanin FQ. Br. J. Pharmacol. 126:1999;555-558.
3. Berger H., Albrecht E., Wallukat G., Calo' G., Bigoni R., Bienert M. Ac-RYYRIK-NH2, a nociceptin/orphanin FQ receptor ligand, exhibits properties of an antagonist and agonist as well. Regul. Pept. 80:1999;122.
4. Bigoni R., Giuliani S., Calo' G., Rizzi A., Guerrini R., Salvadori S., Regoli D., Maggi C.A. Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies. Naunyn Schmiedeberg's Arch. Pharmacol. 359:1999;160-167.
5. 2 is an agonist of the nociceptin (ORL1) receptor. Eur. J. Pharmacol. 349:1998;R5-R6.
6. 2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist. J. Med. Chem. 41:1998;3360-3366.
7. 2, a novel selective nociceptin receptor antagonist, Proceeding of the International Narcotics Research Conference Meeting, S1-5, Saratoga Springs, New York, July 10-15 (1999).
8. Calo G., Rizzi A., Marzola G., Guerrini R., Salvadori S., Beani L., Regoli D., Bianchi C. Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. Br. J. Pharmacol. 125:1998;373-378.
9. 2, a peripheral ORL-1 receptor antagonist, acts as an agonist in the rat spinal cord. Br. J. Pharmacol. 125:1998;949-951.
10. 2 activation of an inward rectifier as a partial agonist of ORL1 receptors in rat periaqueductal gray. Br. J. Pharmacol. 128:1999;103-107.
11. Connor M., Vaughan C.W., Chieng B., Christie M.J. Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurons in vitro. Br. J. Pharmacol. 119:1996;1614-1618.
12. 2+ in the SH-SY5Y human neuroblastoma cell line. Br. J. Pharmacol. 118:1996;205-207.
13. Dooley C.T., Spaeth C.G., Berzeteigurske I.P., Craymer K., Adapa I.D., Brandt S.R., Houghten R.A., Toll L. Binding and in vitro activities of peptides with high affinity for the nociceptin/orphanin FQ receptor, ORL1. J. Pharmacol. Exp. Ther. 283:1997;735-741.
14. Guerrini R., Calo' G., Rizzi A., Bigoni R., Bianchi C., Salvadori S., Regoli D. A new selective antagonist of the nociceptin receptor. Br. J. Pharmacol. 123:1998;163-165.
15. Knoflach F., Reinscheid R.K., Civelli O., Kemp J.A. Modulation of voltage-gated calcium channels by orphanin FQ in freshly dissociated hippocampal neurons. J. Neurosci. 16:1996;6657-6664.
16. + channel in Xenopus oocytes. Br. J. Pharmacol. 120:1997;986-987.
17. Meunier J.-C. Nociceptin /orphanin FQ and the opioid receptor like ORL1 receptor. Eur. J. Pharmacol. 340:1997;1-15.
18. Noda Y., Mamiya T., Nabeshima T., Nishi M., Higashioka M., Takeshima H. Loss of antinociception induced by naloxone benzoylhydrazone in nociceptin receptor-knockout mice. J. Biol. Chem. 273:1998;18047-18051.
19. Okawa H., Hirst R.A., Smart D., McKnight A.T., Lambert D.G. Studies on the coupling of recombinant ORL1 receptors to adenylyl cyclase. Br. J. Pharmacol. 123:1998;218.
20. 2 in the rat brain, rat vas deferens, and CHO cells expressing recombinant human nociceptin receptors. Br. J. Pharmacol. 127:1999;123-130.
21. Polidori C., Calo G., Ciccocioppo R., Guerrini R., Regoli D., Massi M. Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist. Psychopharmacology. 1999;. in press.
22. 2 antagonizes nociceptin effects in the mouse colon. Eur. J. Pharmacol. 1999;. in press.
23. Salvadori S., Guerrini R., Calo' G., Regoli D. Structure activity studies on nociceptin/orphanin FQ: from full agonist, to partial agonist, to pure antagonist. Il Farmaco. 1999;. in press.
24. Vaughan C.W., Ingram S.L., Christie M.J. Action of ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro. J. Neurosci. 17:1997;996-1003.
25. Wnendt S., Kruger T., Janocha E., Hildebrandt D., Englberger W. Agonistic effect of buprenorphine in a Nociceptin/OFQ receptor-triggered reporter gene assay. Mol. Pharmacol. 56:1999;334-338.
26. 2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cord. Neurosci. Lett. 249:1998;127-130.
27. Zaki P.A., Evans C.J. ORL-1: an Awkward child of the opioid receptor family. Neuroscientist. 4:1998;172-184.